We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS denied Friday that its termination of a prominent public relations consultant had anything to do with the recent controversy over the FDA Commissioner’s presentation on convalescent plasma as a COVID-19 treatment, while the FDA refused to shed any light on the reported firing of its head spokesperson. Read More
President Trump vowed during his acceptance speech at the Republican National Convention that a coronavirus vaccine will be ready by the end of the year even as many experts continue to express skepticism about such an expedited timeline. Read More
The FDA has detailed how the agency’s Office of Generic Drugs (OGD) will handle requests for drug application ownership transfers in a new manual of policies and procedures (MAPP). Read More
Ology Bioservices, an Alachua, Fla.-based biologics contract development and manufacturing organization (CDMO), has been granted a contract worth up to $106.3 million from the U.S. Army to help out with COVID-19 vaccine and therapeutic production. Read More
The European Commission is ramping up its efforts to obtain COVID-19 vaccines for EU member states. The commission and AstraZeneca (AZ) signed a contract yesterday for the drugmaker to supply up to 400 million COVID-19 vaccine doses for the EU. Read More